Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes

Journal of Investigative Dermatology

Volumn 120, Issue 6, 2003, Pages 1007-1015

  Greig, Aina V H ^a   Linge, Claire ^b   Terenghi, Giorgio ^a   McGrouther, D Angus ^c   Burnstock, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Proliferation; Purinergic receptors; Skin

Indexed keywords

CYTOKERATIN; CYTOKERATIN K10; INVOLUCRIN; KI 67 ANTIGEN; PURINE P2X RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE RECEPTOR; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; KERATINOCYTES; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0038129501     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12261.x     Document Type: Article

References (42)

1. 2Y purinoceptors? Pharmacol Ther 64:445-475, 1994
2. Abbraccbio MP, Burnstock G: Purinergic signalling: Pathophysiological roles. Jpn J Pharmacol 78:113-145, 1998
3. Burnstock G: A basis For distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds). Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York: Raven Press, 1978; p 107-118
4. Burnstock G: Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-373, 2002
5. Cook PW, Ashton NM, Pittelkow MR: Adenosine and adenine nucleotides inhibit the autonomous and epidermal growth factor-mediated proliferation of cultured human keratinocytes. J Invest Dermatol 104:976-981, 1995
6. Coutinho-Silva R, Persechini PM, Bisaggio RD, et al: P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 276:C1139-1147, 1999
7. 2 receptors. Br J Pharmacol 127:1680-1686, 1999
8. Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424, 1997
9. Eichner R, Sun T-T, Aebi U: The role of keratin subfamilies and keratin pairs in the formation of human epidermal filaments. J Cell Biol 102:1767-1777, 1986
10. Ferrari D, Los M, Bauer MK, Vandenabeele P, Wesselborg S, Schulze-Osthoff K: P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett 19:71-75, 1999
11. Ferrari D, Villalba M, Chiozzi P, Falzoni S, Ricciardi-Castagnoli P, Di Virgilio F: Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 156:1531-1539, 1996
12. Gandarillas A, Goldsmith LA, Gschmeissner S, Leigh IM, Watt FM: Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol 8:71-79, 1999
13. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
14. Gerdes J, Li L, Schlueter C, Duchrow M, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
15. Gillies RJ, Didier N, Denton M: Determination of cell number in monolayer cultures. Anal Biochem 159:109-113, 1986
16. 7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res 296:599-605, 1999
17. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR: Expression of P2 receptors in bone and cultured bone cells. Bone 27:503-510, 2000
18. Khakh BS, Barnard EA, Burnstock G, et al: P2X receptors. In: Girdlestone D (ed). The IUPHAR Compendium of Receptor Characterization and Classification. London: IUPHAR Media Ltd, 2000; p 290-305
19. Khakh BS, Burnstock G, Kennedy C, et al: International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118, 2001
20. King BF, Burnstock G: Purinergic receptors. In: Pangalos M, Davies C (eds). Understanding G Protein-Coupled Receptors and Their Role in the CNS. Oxford: Oxford University Press, 2002; p 422-438
21. Kueng W, Silber E, Eppenberger U: Quantification of cells cultured on 96-well plates. Anal Biochem 182:16-19, 1989
22. von Kügelgen I, Wetter A: Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedebergs Arch Pharmacol 362:310-323, 2000
23. Lee WK, Cboi SW, Lee H-R, Lee E-J, Lee K-H, Kim HO: Purinoceptor-mediated calcium mobilization and proliferation in HaCaT keratinocytes. J Dermatol Sci 25:97-105, 2001
24. Leigh IM, Lane EB, Watt FM (eds). The Keratinocyte Handbook. Cambridge: Cambridge University Press, 1994
25. Llewellyn-Smith IJ, Pilowsky P, Minson JB: The tungstate-stabilized tetramethylbenzidine reaction for light and electron microscopic immunocytochemistry and for revealing biocytin-filled neurons. J Neurosci Meth 46:27-40, 1993
26. McCall CA, Cohen JJ: Programmed cell death in terminally diferentiating keratinocytes, role of endogenous endonuclease. J Invest Dermatol 97:111-114, 1991
27. Miyagawa S, Okada N, Takasaki Y, et al: Expression of proliferating cell nuclear antigen/cyclin m human keratinocytes. J Invest Dermatol 93:678-681, 1989
28. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 22:306, 1997
29. North RA, Surprenant A: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580, 2000
30. 7. Drug Devel Research 47:189-195, 1999
31. Pillai S, Bickle D: Adenosine triphosphate stimulates phosphoinositide metabolism, mobilises intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J Clin Invest 90:42-51, 1992
32. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR: Apoptosis in human skin development, morphogenesis, periderm and stem cells. Dev Dyn 199:176-188, 1994
33. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492, 1998
34. 5 receptor on satellite cells. J Cell Biol 158:345-355, 2002
35. Ryten M, Hoebertz A, Burnstock G: Sequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle. Dev Dyn 221:331-341, 2001
36. Schweizer J, Winter H: Keratin biosynthesis in normal mouse epithelia and in squamous cell carcinoma. J Biol Chem 258:13268-13272, 1983
37. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G: The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738, 1996
38. Tamada Y, Takama H, Kitamura T, Yokochi K, Nitta Y, Ikeya T, Matsumoto Y: Identification of programmed cell death in normal human skin tissues by using specific labelling of fragmented DNA. Br J Dermatol 131:521-524, 1994
39. Terenghi G, Chen S-T, Carrington AL, Polak JM, Tomlinson DR: Changes in sensory neuropeptides in dorsal root ganglia and spinal cord of BB diabetic rats. Acta Diabetologica 31:198-204, 1994
40. Watt FM: Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81:100s-103s, 1983
41. Weil M, Raff MC, Braga VM: Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 9:361-364, 1999
42. Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD: Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112:279-288, 1991